Menopause drug to treat hot flushes and night sweats gets MHRA approval

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the use of fezolinetant – manufactured under the brand name of Veoza – to treat hot flushes and night sweats associated with the menopause. Julian Beach, interim executive director of healthcare quality and access at the MHRA, said the organisation was pleased to approve the... Read moreThe post Menopause drug to treat hot flushes and night sweats gets MHRA approval appeared first on Nursing in Practice.

Source: Nursing in Practice - December 19, 2023 Category: Nursing Authors: Megan Ford Tags: Clinical Latest news Women's health Source Type: news